Ceribell, Stock Working Capital
| CBLL Stock | 26.31 1.08 4.28% |
CeriBell, fundamentals help investors to digest information that contributes to CeriBell,'s financial success or failures. It also enables traders to predict the movement of CeriBell, Stock. The fundamental analysis module provides a way to measure CeriBell,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CeriBell, stock.
Net Working Capital is expected to rise to about 40.1 M this year, although the value of Change In Working Capital will most likely fall to (3.9 M). CeriBell, |
CeriBell, Company Working Capital Analysis
CeriBell,'s Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current CeriBell, Working Capital | 30.36 M |
Most of CeriBell,'s fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CeriBell, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CeriBell, Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for CeriBell, is extremely important. It helps to project a fair market value of CeriBell, Stock properly, considering its historical fundamentals such as Working Capital. Since CeriBell,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CeriBell,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CeriBell,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, CeriBell, has a Working Capital of 30.36 M. This is 92.87% lower than that of the Healthcare sector and 97.77% lower than that of the Medical Devices industry. The working capital for all United States stocks is 97.95% higher than that of the company.
CeriBell, Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CeriBell,'s direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CeriBell, could also be used in its relative valuation, which is a method of valuing CeriBell, by comparing valuation metrics of similar companies.CeriBell, is currently under evaluation in working capital category among its peers.
CeriBell, Fundamentals
| Total Debt | 11.83 M | ||||
| Number Of Employees | 229 | ||||
| Total Asset | 58.92 M | ||||
| Retained Earnings | (126.49 M) | ||||
| Working Capital | 30.36 M | ||||
| Net Asset | 58.92 M |
About CeriBell, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CeriBell,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeriBell, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeriBell, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out CeriBell, Piotroski F Score and CeriBell, Altman Z Score analysis. For more information on how to buy CeriBell, Stock please use our How to buy in CeriBell, Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell,. If investors know CeriBell, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CeriBell, is measured differently than its book value, which is the value of CeriBell, that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell,'s value that differs from its market value or its book value, called intrinsic value, which is CeriBell,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell,'s market value can be influenced by many factors that don't directly affect CeriBell,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.